Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Pharmacology
|
November 1, 1990
Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin
K Bachmann, M Nunlee, M Martin, et al.
Journal of Applied Physics
|
March 12, 2025
Grain growth and superconductivity of rhenium electrodeposited from water-in-salt electrolytes
William D Sides, Ehsan Hassani, David P Pappas, et al.
Virology Journal
|
May 18, 2013
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma
Mark D Sides, Meredith L Sosulski, Fayong Luo, et al.
Virology Journal
|
October 7, 2011
Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies
Mark D Sides, Gregory J Block, Reid W Chadwick, et al.
Respiratory Research
|
April 26, 2014
Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo
Fayong Luo, Yan Zhuang, Mark D Sides, et al.
American Journal of Therapeutics
|
July 1, 1995
The Influence of Dirithromycin on the Pharmacokinetics of Cyclosporine in Healthy Subjects and in Renal Transplant Patients
Kenneth Bachmann, Timothy J. Sullivan, James H. Reese, et al.
Virology
|
May 25, 2011
Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells
Mark D Sides, Gregory J Block, Bin Shan, et al.
The Journal of Sexual Medicine
|
July 15, 2006
Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate
Gregory A Broderick, Craig F Donatucci, Dimitrios Hatzichristou, et al.
Journal of Clinical Pharmacology
|
September 1, 1996
Tonsillar tissue penetration of dirithromycin after multiple doses
J M Benson, J Arnold, S C Manning, et al.
The Journal of Rheumatology
|
March 3, 2005
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis
John D Bradley, Alexei A Dmitrienko, Alan J Kivitz, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Pharmacology
|
November 1, 1990
Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin
K Bachmann, M Nunlee, M Martin, et al.
Journal of Applied Physics
|
March 12, 2025
Grain growth and superconductivity of rhenium electrodeposited from water-in-salt electrolytes
William D Sides, Ehsan Hassani, David P Pappas, et al.
Virology Journal
|
May 18, 2013
Co-treatment with arsenic trioxide and ganciclovir reduces tumor volume in a murine xenograft model of nasopharyngeal carcinoma
Mark D Sides, Meredith L Sosulski, Fayong Luo, et al.
Virology Journal
|
October 7, 2011
Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies
Mark D Sides, Gregory J Block, Reid W Chadwick, et al.
Respiratory Research
|
April 26, 2014
Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo
Fayong Luo, Yan Zhuang, Mark D Sides, et al.
American Journal of Therapeutics
|
July 1, 1995
The Influence of Dirithromycin on the Pharmacokinetics of Cyclosporine in Healthy Subjects and in Renal Transplant Patients
Kenneth Bachmann, Timothy J. Sullivan, James H. Reese, et al.
Virology
|
May 25, 2011
Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells
Mark D Sides, Gregory J Block, Bin Shan, et al.
The Journal of Sexual Medicine
|
July 15, 2006
Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate
Gregory A Broderick, Craig F Donatucci, Dimitrios Hatzichristou, et al.
Journal of Clinical Pharmacology
|
September 1, 1996
Tonsillar tissue penetration of dirithromycin after multiple doses
J M Benson, J Arnold, S C Manning, et al.
The Journal of Rheumatology
|
March 3, 2005
A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis
John D Bradley, Alexei A Dmitrienko, Alan J Kivitz, et al.
Page
of 4